Kuş Evrim, Gürbüz Yeşim, Aydin Omer
Department of Pathology, Medicine Faculty of Kocaeli University, Kocaeli, Turkey.
Kulak Burun Bogaz Ihtis Derg. 2010 Mar-Apr;20(2):77-83.
To determine if there are differences in the expressions of the E-cadherin adhesion molecule of precancerous laryngeal lesions classified according to Ljubljana and World Health Organization (WHO) classification.
We examined 41 cases (3 females, 38 males; mean age 54 years; range 8 to 80 years) of laryngeal hyperplastic-dysplastic lesions from the Kocaeli University Pathology Department archives between 1998-2005. Forty-one laryngeal hyperplastic-dysplastic lesions were classified according to Ljubljana and WHO classification. The cases were classified as pertaining to either low or high risk groups. Sections were stained according to the E-cadherin immunohistochemical method. The relations between risk groups in two different classification systems and E-cadherin expression frequency were detected by Chi-square test.
According to the WHO classification, the loss of expression detected 32.1% (9/28) in high-risk epithelium and 15.4% (2/13) in low-risk epithelium (p=0.26). According to the Ljubljana classification, the loss of expression detected 38.1% (8/21) in high-risk epithelium and 15% (3/20) in low-risk epithelium (p=0.09).
E-cadherin expression is down regulated with histologic progression in the precancerous lesions of the larynx. However, the presence of normal expression in some carcinoma insitu cases limited their diagnostic value. The presence of normal E-cadherin expression in laryngeal squamous cell carcinoma support this opinion. The Ljubljana system is more accurate for predicting the E-cadherin expression's decrease, or in other words, for demonstrating its malignant potential.
确定根据卢布尔雅那和世界卫生组织(WHO)分类的喉癌前病变中E-钙黏蛋白黏附分子的表达是否存在差异。
我们检查了1998年至2005年间科贾埃利大学病理科档案中的41例喉增生-发育异常病变(3例女性,38例男性;平均年龄54岁;范围8至80岁)。41例喉增生-发育异常病变根据卢布尔雅那和WHO分类进行分类。这些病例被分为低风险或高风险组。切片采用E-钙黏蛋白免疫组化方法染色。通过卡方检验检测两种不同分类系统中风险组与E-钙黏蛋白表达频率之间的关系。
根据WHO分类,高风险上皮中表达缺失为32.1%(9/28),低风险上皮中为15.4%(2/13)(p=0.26)。根据卢布尔雅那分类,高风险上皮中表达缺失为38.1%(8/21),低风险上皮中为15%(3/20)(p=0.09)。
在喉癌前病变中,E-钙黏蛋白表达随组织学进展而下调。然而,一些原位癌病例中正常表达的存在限制了它们的诊断价值。喉鳞状细胞癌中正常E-钙黏蛋白表达的存在支持了这一观点。卢布尔雅那系统在预测E-钙黏蛋白表达降低方面,或者换句话说,在显示其恶性潜能方面更为准确。